skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study

Journal of Atherosclerosis and Thrombosis, 2021, pp.63076

2021 This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License. ;ISSN: 1340-3478 ;EISSN: 1880-3873 ;DOI: 10.5551/jat.63076

Full text available

Citations Cited by
  • Title:
    Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study
  • Author: Lin, Jia-Ling ; Chen, Po-Sheng ; Lin, Hui-Wen ; Tsai, Liang-Miin ; Lin, Sheng-Hsiang ; Li, Yi-Heng
  • Subjects: Adverse events ; Asians ; Statin
  • Is Part Of: Journal of Atherosclerosis and Thrombosis, 2021, pp.63076
  • Description: Aim: The safety concern of statins is still a major issue for Asians. The aim of this study is to compare the risk of statin-associated adverse events among potent statins. Methods: We included patients from the Taiwan National Health Insurance Research Database who had been treated with atorvastatin, rosuvastatin, or pitavastatin and were without diabetes at baseline. They were classified into three groups: usual-dose statin (atorvastatin 10 mg/d or rosuvastatin 5–10 mg/d), high-dose statin (atorvastatin 20–40 mg/d and rosuvastatin 20 mg/d), and pitavastatin (2–4 mg/d). The primary endpoint is a composite of safety events, including hepatitis, myopathy, and new-onset diabetes mellitus (NODM). We matched age, sex, and year of recruitment among the three groups (n=50,935 in each group) and then used the multivariate Cox proportional hazards model to evaluate the relation between the safety endpoint and different statin groups. Results: After a mean follow-up of 3.08±0.83 years, the safety events occurred in 9.84% in the pitavastatin group, 10.88% in the usual-dose statin group, and 10.49% in high-dose statin group. The multivariate Cox proportional hazards model indicated that usual-dose statin and high-dose statin were associated with a higher risk of the composite safety events compared with pitavastatin (adjusted hazard ratio [aHR]: 1.12, 95% confidence interval [CI]: 1.08–1.17 for usual-dose statin and aHR: 1.06, 95% CI: 1.02–1.10 for high-dose statin). The risks of hepatitis requiring hospitalization and NODM were especially lower in pitavastatin group. Conclusions: Compared with atorvastatin and rosuvastatin, pitavastatin might be associated with a lower risk of safety events in Asians.
  • Publisher: Japan Atherosclerosis Society
  • Language: English
  • Identifier: ISSN: 1340-3478
    EISSN: 1880-3873
    DOI: 10.5551/jat.63076
  • Source: GFMER Free Medical Journals
    PubMed Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait